Ataxion, a spinout company of biotechnology firm Saniona, is set to merge with Luc Therapeutics.

The merged company will continue to operate as Luc Therapeutics, in which Saniona will hold 7.1% stake and rights to royalties of marked products from the Ataxia programme.

Saniona is based in Denmark, whereas Luc Therapeutics is based in the US.

Kasten has merged with Thru Pharma (doing business as DAKOTA Life Sciences), a company which develops innovative health products such as antifungals and antibiotics using site-specific penetration technologies.

"US-based biopharmaceutical company Heat Biologics is set to acquire 80% stake in Pelican Therapeutics."

US-based biopharmaceutical company Heat Biologics is set to acquire 80% stake in Pelican Therapeutics.

The purchase consideration includes $0.5m in cash and issuance of 1.3 shares of Heat Biologics’ common stock.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The acquisition is expected to be completed on or before 30 April.

Pelican Therapeutics is an immune-oncology company also based in the US.